FOXO1 and neoplasm: Finally, we validated the FOXO1 target by generating a reporter construct, and luciferase experiments also indicated that FOXO1 luciferase activity increased in T-DM1-treated tumor cells (Fig. 8K and Supplementary Fig. S5).